Toxin binding of tolevamer, a polyanionic drug that protects against antibiotic-associated diarrhea

Biophysical Journal
William BraunlinC B Kurtz

Abstract

Tolevamer, (GT160-246), is a sodium salt of styrene sulfonate polymer that is under development for the treatment of diarrhea caused by infection with Clostridium difficile. Pulsed ultrafiltration binding experiments in phosphate buffer containing 0.15 M Na(+) provide per polymer chain dissociation constants of 133 nM and 8.7 microM for the binding of tolevamer to C. difficile toxins A and B, respectively. At 0.05 M Na(+), the binding of toxin A to tolevamer is irreversible, whereas the dissociation constant to toxin B under these conditions is 120 nM. Binding constants obtained from fluorescence polarization data for toxin A binding to tolevamer at 0.15 M Na(+) agree substantially with those obtained by pulsed ultrafiltration. The binding activity of tolevamer reported here correlates well with previously reported results for the inhibition of the biological activity of C. difficile toxins A and B. From the fluorescence polarization data, it is estimated that one toxin A molecule interacts with between 600 to 1000 monomer units on tolevamer at 0.15 M Na(+). Thus, the data suggest a very large interaction surface between polymer and toxin A.

References

Mar 17, 1975·JAMA : the Journal of the American Medical Association·E J Burbige, F D Milligan
Jan 1, 1990·Annual Review of Biophysics and Biophysical Chemistry·C F Anderson, M T Record
Jan 1, 1988·Clinical Microbiology Reviews·D M LyerlyT D Wilkins
Oct 1, 1987·Journal of Biochemical and Biophysical Methods·R C Chatelier, W H Sawyer
Aug 13, 1985·Biochemistry·K E van Holde, K I Miller
Jan 1, 1980·The Journal of Infectious Diseases·N S Taylor, J G Bartlett
May 1, 1995·The Journal of Clinical Investigation·M RieglerJ T LaMont
Jan 1, 1995·Methods in Enzymology·D M Jameson, W H Sawyer
Mar 3, 1998·Lancet·S G Sheth, J T LaMont
Mar 24, 1998·Annual Review of Medicine·C P Kelly, J T LaMont
Aug 26, 1998·Analytical Biochemistry·C J ChenD L Venton
May 5, 1999·Journal of Chromatography. B, Biomedical Sciences and Applications·C P Woodbury, D L Venton
Apr 4, 2000·Journal of Clinical Microbiology·A P LimayeT R Fritsche
Jul 14, 2001·Antimicrobial Agents and Chemotherapy·C B KurtzJ D Klinger

❮ Previous
Next ❯

Citations

Mar 28, 2008·Archives of Pharmacal Research·Min-Hyo KiHee-Jong Shin
Nov 3, 2005·Nature Clinical Practice. Gastroenterology & Hepatology·Christina M Surawicz
Apr 20, 2006·Nature Structural & Molecular Biology·Antonio GrecoKenneth K-S Ng
Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J LouieUNKNOWN Tolevamer Study Investigator Group
Aug 4, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jacques Pepin
Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John G Bartlett
Jun 10, 2009·British Medical Bulletin·O Martin Williams, Robert C Spencer
Apr 9, 2008·Antimicrobial Agents and Chemotherapy·Paul L HinksonRobert H Barker
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Simon D BainesMark H Wilcox
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jason G S HoKenneth K-S Ng
Apr 29, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Herbert L DuPont
Oct 17, 2008·Expert Opinion on Investigational Drugs·Joseph GuilesXicheng Sun
May 17, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nicolas BertrandJeanne Leblond
Aug 18, 2009·Advanced Drug Delivery Reviews·Pradeep K DhalRobert J Miller
Dec 27, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Simon KeelyDavid J Brayden
Sep 28, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jing LiDavid Oupický
Oct 10, 2007·Clinics in Geriatric Medicine·Chantri Trinh, Kavita Prabhakar
May 8, 2007·American Journal of Infection Control·Lynne V McFarlandGregory J Raugi
Nov 23, 2006·The Medical Clinics of North America·Emilio BouzaPatricia Muñoz
Aug 2, 2006·Gastroenterology Clinics of North America·Saima Aslam, Daniel M Musher
Jun 1, 2015·Advanced Drug Delivery Reviews·Adam WeismanKenneth J Shea
Nov 23, 2006·The Annals of Pharmacotherapy·Tomasz Z JodlowskiIgor Melnychuk
Mar 24, 2012·Angewandte Chemie·Mattias E IvarssonBastien Castagner
Sep 20, 2012·American Journal of Therapeutics·Josmi JosephSury Anand
Jul 12, 2014·Expert Review of Gastroenterology & Hepatology·Herbert L DuPont
Mar 2, 2019·Journal of Biological Engineering·Eric Krueger, Angela C Brown

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.